Education
About Us
Working with TipRanks
Follow Us
Implanet SA (DE:IM11)
FRANKFURT:IM11
IM11 Stock Chart & Stats
€0.28
>-€0.01(-1.68%)
At close: 4:00 PM EST
€0.28
>-€0.01(-1.68%)
Day’s Range― - ―
52-Week Range€0.08 - €0.42
Previous CloseN/A
Volume0.00
Average Volume (3M)4.40K
Market Cap
€28.71M
Enterprise Value€17.61M
Total Cash (Recent Filing)€502.00K
Total Debt (Recent Filing)€6.12M
Price to Earnings (P/E)―
Beta0.31
Next Earnings
Mar 10, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding143,543,910
10 Day Avg. Volume3,845
30 Day Avg. Volume4,401
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)18.30
Price to Sales (P/S)1.41
P/FCF Ratio-4.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IM11 FAQ
What was Implanet SA’s price range in the past 12 months?
Implanet SA lowest stock price was €0.07 and its highest was €0.42 in the past 12 months.
What is Implanet SA’s market cap?
Implanet SA’s market cap is €28.71M.
When is Implanet SA’s upcoming earnings report date?
Implanet SA’s upcoming earnings report date is Mar 10, 2026 which is in 72 days.
How were Implanet SA’s earnings last quarter?
Implanet SA released its earnings results on Sep 16, 2025. The company reported -€0.017 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.017.
Is Implanet SA overvalued?
According to Wall Street analysts Implanet SA’s price is currently Overvalued.
Does Implanet SA pay dividends?
Implanet SA does not currently pay dividends.
What is Implanet SA’s EPS estimate?
Implanet SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Implanet SA have?
Implanet SA has 143,543,910 shares outstanding.
What happened to Implanet SA’s price movement after its last earnings report?
Implanet SA reported an EPS of -€0.017 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 6.667%.
Which hedge fund is a major shareholder of Implanet SA?
Currently, no hedge funds are holding shares in DE:IM11
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Implanet SA
Implanet S.A., together with its subsidiaries, researches and develops, manufactures, and sells spinal and orthopedic implants. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. The company also provides knee prostheses under the Madison name. Implanet S.A. has a strategic partnership with Shanghai Sanyou Medical Co, Ltd. The company was founded in 2006 and is based in Martillac, France.
Technical Analysis
Theraclion SA
―
Diagnostic Medical Systems
―
Ikonisys SA
―
Euromedis Groupe SA
―
Median Technologies
―